To view this email as a web page, click here.
 
Self-injectable respiratory medication opens doors for patients with severe asthma
The first respiratory biologic to be approved for administration via an autoinjector will be available in the US soon.
Read more
 
How mergers change specialty pharmacy
From our sister brand, Managed Healthcare Executive: At the 2019 Asembia Specialty Pharmacy Summit, an expert discussed how the evolving healthcare landscape means that key players must re-evaluate to thrive under these new market forces.
Read more
 
FDA clears first cluster headache drug of its type
FDA cleared the first-and-only calcitonin gene-related peptide (CGRP) antibody for cluster headaches.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.